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A B S T R A C T
Serotonin toxicity syndrome is a potentially life-threatening condition caused by 
excessive serotonergic activity in the nervous system. It is characterized by mental 
status changes, autonomic instability, and neuromuscular hyperactivity. Critically ill 
patients may require neuromuscular paralysis, sedation, and intubation. If serotonin 
syndrome is recognized and complications are managed appropriately, the prognosis 
is favorable. In the present case, we discuss the clinical presentation and outcome of 
the serotonin syndrome which was developed in a 30-year-old pregnant woman with a 
medical history of depression managed by selective serotonin-noradrenaline reuptake 
inhibitors. This case is presented to inform physicians about our observations regard-
ing the results of blood gases and to discuss a possible explanation.
I n T R o d u C T I o n
Serotonin syndrome is a toxic condition of the central nervous system which is due to 
the increased serotonergic activity in the spinal cord caused by the increased sensitivity 
of serotonin receptors.1 Serotonin syndrome is induced by the use of pharmacologic 
agents that increase serotonergic activity. Serotonergic agents include medications that 
inhibit serotonin reuptake (selective serotonin reuptake inhibitors [SSRIs], tricyclic 
antidepressants), medications that increase serotonin release (amphetamines, opioid 
analgesics), agents that inhibit serotonin metabolism (monoamine oxidase inhibitors, 
linezolid), and post-synaptic serotonin receptor agonists (buspirone, carbamazepine).
Diagnosis is made based on clinical symptoms; no radiologic or laboratory method 
exists for diagnosis. Neuromuscular excitation (including clonus, myoclonus, tremor, 
and hyperreflexia), autonomic excitation (including fever, mydriasis, tachycardia, and 
tachypnea), changes in mental status (agitation and confusion), and changes in vital 
signs (fever, tachycardia, and hypertension) are the m ost important clinical symptoms. 
Leukocytosis, increased serum creatinine, elevated liver enzymes, and acidosis can be 
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aPTT = activated partial thromboplastin 
time
Hbf = fetal hemoglobin
Hb = hemoglobin
INR = international normalized ratio
PO2 = partial pressure of oxygen
SGOT = serum glutamic oxaloacetic 
transaminase
SGPT = serum glutamic pyruvic 
transaminase
SSRIs = selective serotonin reuptake 
inhibitors
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observed in some patients. The spectrum of serotonin toxicity 
extends from mild side effects, to severe coma that can result 
in death.2,3 Herein we present a case of serotonin syndrome 
that was induced by the use of a SSRI. The most impressive 
finding was related to the results of blood gas values which 
we try to explain.
C A S e  p R e S e n T A T I o n
A 30-year-old pregnant woman was admitted to the de-
livery room, at 30 weeks of gestation, due to pre-eclampsia 
and stained amniotic fluid. She had a past medical history 
of depression managed by selective serotonin-noradrenaline 
reuptake inhibitors (venlafaxine in dose 75 mg/day). Because 
of the very low heart rate of the fetus, the patient underwent 
an emergency caesarean section. A dead baby was delivered.
The patient was admitted to the intensive care unit for 
further support. The laboratory reports indicated elevated 
liver enzymes (SGPT: 537 U/L, SGOT: 298 U/L), renal failure 
(urea: 69 mg/dl, creatinine: 2.52 mg/dl), high leukocyte count 
(27.800/mm³), platelet count of 140,000/mm3, and hemoglobin 
level of 12.4 mmol/l. The coagulation profile was abnormal 
(INR: 1.66, aPTT: 46 seconds). She had a pulse rate of 85/min, 
respiratory rate of 18/min, blood pressure of 110/70 mmHg, 
temperature of 39°C, and oxygen saturation of 99% on room 
air. She was neither fully alert nor oriented with Glasgow coma 
scale score of 10/15.
Half an hour later, the patient lost her consciousness. 
Physical examination revealed mild bilateral mydriasis, nystag-
mous, salivation, positive oculocephalic reflexes, presentation 
of stiff neck and lateralization in motor examination, active 
deep tendon reflexes, no Babinski reflex, flushing of the skin, 
tachycardia without arrhythmia, and severe hypertonicity. No 
additional pathological findings were observed. Both the psy-
chiatric and neurological consultations recommended magnetic 
resonance imaging of the brain which was normal. Cardiology 
consultation revealed no cardiac problem. Toxicology blood 
tests revealed high venlafaxine levels (1551 μg/l, normal range: 
195-400 μg/dl). The diagnosis of serotonin toxicity syndrome was 
established.1,4 Patient’s management included discontinuation 
of the responsible drug, supportive care, control of agitation, 
and treatment of autonomic dysfunction and hyperthermia.5
However, the most impressive findings were the results 
of blood gas analysis. In particular, the right radial artery and 
a left forearm vein were cannulated. In the first three hours 
following patient’s admission, blood samples from both vessels 
(artery and vein) were received every one hour. Table 1 sum-
marizes our findings. During the first two hours, the arterial 
and venous blood gas values were similar, but they started to 
differentiate by the time the third blood sample was taken. 
It was by that time when the patient started to get stabilized 
and the majority of her serotonin toxicity syndrome symptoms 
receded. From then onwards, the blood gas values were predict-
able, the patient was stable, and she was discharged in good 
health the following day.
d I S C u S S I o n
The diagnosis of serotonin toxicity syndrome is suggested 
with a sensitivity of 84% and specificity of 97% by the Hunter 
TABle 1. Arterial and venous blood gas values during the first three hours after patient’s admission
1st hour 2nd hour 3rd hour
Arterial Venous Arterial Venous Arterial Venous
pH 7.278 7.274 7.272 7.278 7.365 7.334
pCO2 33.0 mmHg 30.3 mmHg 33.9 mmHg 32.9 mmHg 30.5 mmHg 37.0 mmHg
pO2 133 mmHg 102 mmHg 114 mmHg 104 mmHg 125 mmHg 46.4 mmHg
Hb 12.5 g/dl 15.1 g/dl 12.8 g/dl 13.1 g/dl 12.2 g/dl 12.7 g/dl
SpO2 99% 97.4% 98% 97.8% 98.8% 86%
FCOHb 0.6% 0.3% 0.6% 0.7% 0.6% 0.7%
FHHb 1.0% 2.6% 2.0% 2.2% 1.2% 13.8%
FMetHb 0.7% 0.6% 0.7% 0.7% 0.7% 0.8%
FO2Hb 97.7% 96.5% 96.7% 96.4% 97.5% 84.7%
HCO3 14.9 mmol/l 13.6 mmol/l 15.1 mmol/l 14.9 mmol/l 17.0 mmol/l 19.2 mmol/l
FCOHb = fraction of carboxyhemoglobin; FHHb = fraction of deoxyhemoglobin in total hemoglobin; FO2Hb = fraction of oxyhemoglobin; 
FMetHb = fraction of methemoglobin; Hb = hemoglobin; HCO3 = bicarbonate; pCO2 = partial pressure of CO2; pO2 = partial pressure of oxygen; 
SpO2 = oxygen saturation.
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serotonin toxicity criteria in the presence of a serotonergic 
agent and one of the following symptoms: spontaneous clonus, 
inducible clonus and agitation or diaphoresis, ocular clonus and 
agitation or diaphoresis, tremor and hyperreflexia, hypertonia 
and temperature >38°C, and ocular clonus or inducible clonus.2 
The Hunter criteria have not been validated in patients who 
develop serotonin toxicity on therapeutic doses of serotonergic 
agents. In our patient, elevated liver enzymes, renal failure, 
leukocytosis, and high temperature were observed. Further-
more, physical examination revealed nystagmous, salivation, 
positive oculocephalic reflexes, presentation of stiff neck and 
lateralization in motor examination, active deep tendon reflexes, 
flushing of the skin, tachycardia, and severe hypertonicity.
The management of this syndrome varies depending on 
the severity of symptoms and includes removal of responsi-
ble medications, supportive care, cyproheptadine (a 5-HT2A 
antagonist), control of agitation (with benzodiazepines, such 
as lorazepam), and treatment of autonomic dysfunction and 
hyperthermia.6 With appropriate management, symptoms 
resolve within 24 hours in about 60% of all cases, but drugs 
with longer duration of action or active metabolites may cause 
prolonged symptoms.1
In this case, the possible scenarios to explain all the obser-
vations according to blood gas results could be the following. 
Firstly, the occurrence of an arteriovenous malformation which 
in our case is not possible as this phenomenon was observed 
for a limited period of time. Secondly, the findings could have 
been the result of serotonin toxicity syndrome, a scenario sup-
ported by the fact that this phenomenon was observed in time 
relevance with this syndrome’s symptoms. However, there are 
no literature references or other authors’ similar observation 
to advance this point of view. Finally, blood gas findings could 
have been caused by a large amount of fatal hemoglobin (Hbf 
- no ability to measure it) retrograded through the umbilical 
cord to mother’s circulation. Hbf represents the 80%-85% of 
total Hb in term fetus and has a close chemical relationship 
with O2, committing more amount of O2 than the Hb, even in 
cases of low PO2.2 Hbf does not easily release O2, resulting in 
elevated PO2 levels in mother’s venous blood.
C o n C l u S I o n
Serotonin toxicity syndrome is a potentially life-threatening 
condition. Educating patients, family members, and caregivers 
about these side effects increases the chance of early diagnosis 
and immediate intervention and reduces the risk of death. 
Furthermore, physicians need to be aware of these probable 
risk factors when prescribing antipsychotic treatment. Finally, 
more studies, continued analysis, and further investigation are 
needed to determine if there is any relationship between the 
serotonin toxicity syndrome and abnormal blood gas values 
in pregnancy. According to the present case, the only logical 
assumption to be made is that blood gases might be changed 
during the acute phase of serotonin toxicity syndrome - time 
relevance deserves an organized attempt to replicate findings. 
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